-
Feb 17, 2017, 5:56 pm203 pts
Ars Technica
(credit: ccPixs.com) Last week, Marathon Pharmaceuticals announced that it would start selling an old steroid drug that treats Duchenne muscular dystrophy for a whopping $89,000 per year of treatment. That’s a steep increase from the $1,200-per-year generic version that families could import from other…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.
